Product Information
RIZATRIPTAN 5 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.4541 per EA under NDC 33342008772. Its NADAC has been published 532 times since Mar 11, 2015.
FDA first approved this application on Feb 11, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342008772
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
4/23/2025
Active Ingredients
RIZATRIPTAN BENZOATEApproval Type
Generic (ANDA)
FDA Application
ANDA203147FDA Approved
2/11/2014
TE Code
AB
On Market Since
3/11/2014
Pharmacological Classes
Price Statistics
The NADAC for RIZATRIPTAN 5 MG TABLET has been published 532 times since Mar 11, 2015, and over the history we have for it it has declined 65.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4541 per EA |
|---|---|
| All-time high | $1.3226 (Jul 15, 2015) |
| All-time low | $0.3203 (Jul 17, 2024) |
| Median price | $0.8083 |
| Average price | $0.8044 |
| Largest weekly change | +74.4% (Aug 21, 2024) |
| Weeks tracked | 532 |
| Tracking since | Mar 11, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+1.2%
5Y
-46.5%
All
-65.1%
Last surveyed May 14, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 23% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Macleods Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Rizatriptan market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-1b and Serotonin-1d Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of RIZATRIPTAN 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RIZATRIPTAN 5 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.4541 per EA (NDC 33342008772), effective May 14, 2025.
How has the price of RIZATRIPTAN 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for RIZATRIPTAN 5 MG TABLET has declined 65.1%. It has been tracked across 532 weekly CMS publications since Mar 11, 2015.
What are the highest and lowest recorded NADAC prices for RIZATRIPTAN 5 MG TABLET?
Since Mar 11, 2015, the NADAC for RIZATRIPTAN 5 MG TABLET has ranged from a low of $0.3203 (Jul 17, 2024) to a high of $1.3226 (Jul 15, 2015), with a median of $0.8083 per EA.
Are there cheaper alternatives to RIZATRIPTAN 5 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RIZATRIPTAN 5 MG TABLET, is $0.3480 per EA — about 23% below RIZATRIPTAN 5 MG TABLET.
Who manufactures RIZATRIPTAN 5 MG TABLET?
RIZATRIPTAN 5 MG TABLET (NDC 33342008772) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.